Gyros Protein Technologies introduces PurePep Sonata+ peptide synthesizer

By The Science Advisory Board staff writers

March 3, 2022 -- Gyros Protein Technologies has released its PurePep Sonata+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the company’s previous model, Sonata XT, known for its reliability and robustness, to further strengthen the company’s offering.

The upgrade, PurePep Sonata+, builds on the ability of Sonata XT through the introduction of real-time flow technology, a non-invasive method to continually monitor the flow rate of fluids within the system, which enables accurate and precise fluid transfers for a range of viscosities.

The need to calibrate is thereby minimized, and workflows that previously required one day for fluid calibration are significantly shortened. The company’s proprietary valve block system, the PurePep Pathway, is also integrated to ensure no cross-contamination, for reliable peptide purity.

With a reduced calibration time to streamline and shorten workflows, improved reliability and robustness, the new peptide synthesizer is easy to operate, and the intuitive software platform, designed for 21 Code of Federal Regulations (CFR) Part 11 compliance, facilitates an easy transition from the bench-scale PurePep Chorus to mid-pilot scale.

Gyros Protein Technologies is a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays.

Gyros launches kit to support gene therapy production
Immunoassay developer Gyros Protein Technologies is introducing a new titer kit called Gyrolab AAV9 to support adeno-associated virus-based cell and gene...
Gyros, Cygnus introduce bioprocess impurity immunoassay solution
Gyros Protein Technologies has introduced its new HEK 293 host cell protein (HCP) immunoassay solution in collaboration with Cygnus Technologies. The...
Gyros launches new product to support cell & gene therapy manufacturing
Gyros Protein Technologies introduced a new product for adeno-associated virus vector titer determination.
Gyros immunoassay integrated into TJU training programs
Immunoassay developer Gyros Protein Technologies announced on March 17 that it will integrate its technology into advanced training programs at the Jefferson...

Copyright © 2022

Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter